BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17596315)

  • 1. An adenovirus vector-mediated reverse genetics system for influenza A virus generation.
    Ozawa M; Goto H; Horimoto T; Kawaoka Y
    J Virol; 2007 Sep; 81(17):9556-9. PubMed ID: 17596315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments.
    de Wit E; Spronken MI; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    Virus Res; 2004 Jul; 103(1-2):155-61. PubMed ID: 15163504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.
    Nicolson C; Major D; Wood JM; Robertson JS
    Vaccine; 2005 Apr; 23(22):2943-52. PubMed ID: 15780743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production.
    Neumann G; Fujii K; Kino Y; Kawaoka Y
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16825-9. PubMed ID: 16267134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of influenza virus replication in Vero and MDCK cell lines.
    Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
    J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Vero cell-derived influenza whole virus vaccine.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease.
    Elahi SM; Oualikene W; Naghdi L; O'Connor-McCourt M; Massie B
    Gene Ther; 2002 Sep; 9(18):1238-46. PubMed ID: 12215891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency.
    Yoshioka Y; Asavatanabodee R; Eto Y; Watanabe H; Morishige T; Yao X; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
    Life Sci; 2008 Nov; 83(21-22):747-55. PubMed ID: 18930744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification.
    Stech J; Stech O; Herwig A; Altmeppen H; Hundt J; Gohrbandt S; Kreibich A; Weber S; Klenk HD; Mettenleiter TC
    Nucleic Acids Res; 2008 Dec; 36(21):e139. PubMed ID: 18832366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
    Miura Y; Yoshida K; Nishimoto T; Hatanaka K; Ohnami S; Asaka M; Douglas JT; Curiel DT; Yoshida T; Aoki K
    Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of adenovirus vectors modified with cell-penetrating peptides.
    Eto Y; Yoshioka Y; Asavatanabodee R; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
    Peptides; 2009 Aug; 30(8):1548-52. PubMed ID: 19467282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of influenza C virus from recombinant DNA.
    Crescenzo-Chaigne B; van der Werf S
    J Virol; 2007 Oct; 81(20):11282-9. PubMed ID: 17686850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of recombinant influenza virus using baculovirus delivery vector.
    Poomputsa K; Kittel C; Egorov A; Ernst W; Grabherr R
    J Virol Methods; 2003 Jun; 110(1):111-4. PubMed ID: 12757928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified recombinational approach for influenza A virus reverse genetics.
    Wang S; Liu Q; Pu J; Li Y; Keleta L; Hu YW; Liu J; Brown EG
    J Virol Methods; 2008 Jul; 151(1):74-8. PubMed ID: 18456344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent.
    Opitz L; Zimmermann A; Lehmann S; Genzel Y; Lübben H; Reichl U; Wolff MW
    J Virol Methods; 2008 Dec; 154(1-2):61-8. PubMed ID: 18840469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of various FLP recombinases expressed by adenovirus vectors in mammalian cells.
    Kondo S; Takata Y; Nakano M; Saito I; Kanegae Y
    J Mol Biol; 2009 Jul; 390(2):221-30. PubMed ID: 19414019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
    Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
    Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.